Biotechnology Companies By Ten Year Return
LargestBiggest EarnersMost ProfitableMost LiquidHighly LeveragedTop DividendsCapital-HeavyHighest ValuationLargest Workforce
Ten Year Return
| Ten Year Return | Efficiency | Market Risk | Exp Return | ||||
|---|---|---|---|---|---|---|---|
| 1 | BCTX | Briacell Therapeutics Corp | (0.10) | 10.31 | (1.00) | ||
| 2 | ARGX | argenx NV ADR | 0.14 | 1.57 | 0.22 | ||
| 3 | EXEL | Exelixis | (0.05) | 2.19 | (0.10) | ||
| 4 | VCEL | Vericel Corp Ord | 0.12 | 2.14 | 0.25 | ||
| 5 | KRYS | Krystal Biotech | (0.12) | 2.61 | (0.32) | ||
| 6 | AVXL | Anavex Life Sciences | 0.03 | 7.12 | 0.18 | ||
| 7 | NTRA | Natera Inc | 0.14 | 3.62 | 0.51 | ||
| 8 | SRPT | Sarepta Therapeutics | 0.00 | 2.82 | 0.00 | ||
| 9 | BNTX | BioNTech SE | 0.06 | 3.22 | 0.19 | ||
| 10 | ONC | BeiGene, | 0.08 | 2.72 | 0.22 | ||
| 11 | CYTK | Cytokinetics | (0.13) | 2.68 | (0.34) | ||
| 12 | ASND | Ascendis Pharma AS | 0.02 | 2.43 | 0.04 | ||
| 13 | CPRX | Catalyst Pharmaceuticals | 0.00 | 3.14 | 0.01 | ||
| 14 | BPMC | Blueprint Medicines Corp | 0.06 | 3.33 | 0.21 | ||
| 15 | BLTE | Belite Bio ADR | (0.11) | 4.00 | (0.45) | ||
| 16 | BHVN | Biohaven Pharmaceutical Holding | (0.14) | 3.44 | (0.47) | ||
| 17 | INSM | Insmed Inc | 0.07 | 2.69 | 0.19 | ||
| 18 | VCYT | Veracyte | 0.11 | 3.01 | 0.34 | ||
| 19 | NUVL | Nuvalent | (0.05) | 2.50 | (0.13) | ||
| 20 | MLTX | MoonLake Immunotherapeutics | (0.03) | 3.36 | (0.10) |
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Ten Year Return shows the total annualized return generated from holding a fund for the last 10 years and represents fund's capital appreciation, including dividends losses and capital gains distributions. This return indicator is considered by many investors to be the ultimate measures of fund performance and can reflect the overall performance of the market or market segment it invests in. Although Ten Year Fund Return indicator can give a sense of overall fund long-term potential, it is recommended to compare funds performances against other similar funds or market benchmarks for the same 10-year interval.